Phase 1 Evaluation of [(64)Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors.

Phase 1 Evaluation of [(64)Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors.

Item
http://www.wikidata.org/entity/Q33887412
Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.Noninvasive Imaging of CCR2+ Cells in Ischemia-Reperfusion Injury After Lung Transplantation.64Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model.89Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment.89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors.Phage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a Novel HER3 Peptide.Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab).Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast CancerEvaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts
P2860

Phase 1 Evaluation of [(64)Cu]DOTA-Patritumab to Assess Dosimetry, Apparent Receptor Occupancy, and Safety in Subjects with Advanced Solid Tumors.

Item
http://www.wikidata.org/entity/Q33887412
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@ast
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@en
type
label
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@ast
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@en
prefLabel
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@ast
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Phase 1 Evaluation of [(64)Cu] ...... ts with Advanced Solid Tumors.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P932